SYNERGETIC BLEND COMPOSITIONS BETWEEN AT LEAST ONE RXR SPECIFIC LIGAND AND AT LEAST ONE RAR-amp;#150; SPECIFIC LIGAND; USES THEREOF

摘要

The invention relates to the use of new combinations based on at least a first ligand having a selective activity for the RXRs receptors and at least a second ligand having a selective activity for the RAR-.alpha. Receptor, as principles active in, or for the manufacture of, pharmaceutical and / or dermatological compositions more particularly intended for modulating the proliferation and / or differentiation of a cellular system of the HL60 type, with the aim in particular of treating, systemically, promyelocytic leukemia acute.